| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692502 | The Breast | 2017 | 5 Pages |
Abstract
Breast cancer patients with HCV can be treated with chemotherapy and targeted therapy with trastuzumab. Breast cancer patients with HBV who accept antiviral therapy can be treated with chemotherapy and targeted therapy with trastuzumab and patients can benefit from prophylactic antiviral therapy before chemotherapy. However, a multidisciplinary cooperation and closely monitoring liver function during the course of chemotherapy may benefit patients.
Keywords
ADLTBILDAAsCHBHER-2HBsAgCTCAECHCALTASTAspartate aminotransferaseAlanine aminotransferaseHepatitis B surface antigenprothrombin timeBreast cancerToxicityChemotherapydirect-acting antiviral agentsActivities of daily livingCommon Terminology Criteria for Adverse Eventschronic hepatitis Bchronic hepatitis CHBVHepatitis C virusHCVHepatitis B virus (HBV)Hepatitis C virus (HCV)hepatitis B virustotal bilirubinEstrogen receptorHuman epidermal growth factor receptor 2Progesterone receptor
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Yu Liu, Zhan-Yi Li, Xi Li, Jia-Ni Wang, Qun-Ai Huang, Yong Huang,